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Abstract 
The genomes of ancient humans, Neandertals, and Denisovans contain many alleles that 
influence disease risks. Using genotypes at 3180 disease-associated loci, we estimated the 
disease burden of 147 ancient genomes. After correcting for missing data, genetic risk scores 
were generated for nine disease categories and the set of all combined diseases. These genetic 
risk scores were used to examine the effects of different types of subsistence, geography, and 
sample age on the number of risk alleles in each ancient genome. On a broad scale, hereditary 
disease risks are similar for ancient hominins and modern-day humans, and the GRS percentiles 
of ancient individuals span the full range of what is observed in present day individuals. In 
addition, there is evidence that ancient pastoralists may have had healthier genomes than hunter-
gatherers and agriculturalists. We also observed a temporal trend whereby genomes from the 
recent past are more likely to be healthier than genomes from the deep past. This calls into 
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question the idea that modern lifestyles have caused genetic load to increase over time. Focusing 
on individual genomes, we find that the overall genomic health of the Altai Neandertal is worse 
than 97% of present day humans and that Ötzi the Tyrolean Iceman had a genetic predisposition 
to gastrointestinal and cardiovascular diseases. As demonstrated by this work, ancient genomes 
afford us new opportunities to diagnose past human health, which has previously been limited by 
the quality and completeness of remains. 
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Introduction 
Ancient human remains yield valuable information about the health and disease of individuals 
from the past. Skeletal remains provide details about medical practices (Andrushko and Verano 
2008) and certain diseases, such as cancers (Binder, et al. 2014; Odes, et al. 2016) and rheumatic 
diseases (Entezami, et al. 2011) that visibly alter or affect bone. However, many diseases do not 
leave their mark on bone; instead, they cause soft tissue damage requiring mummified remains 
for diagnosis. One of the best studied set of mummified human remains is the Tyrolean Iceman, 
a well-preserved 5300-year-old Neolithic man discovered in the Ötztal Alps. Examination of his 
remains shows hardening arteries suggesting that this man possessed a predisposition for 
coronary heart disease (Murphy, et al. 2003). Further evidence from the sequencing of the 
Iceman’s genome supports this diagnosis (Keller, et al. 2012) and demonstrates that modern risk 
alleles can accurately predict disease risk in ancient individuals. In addition to heart disease, 
genetic data also indicate that the Iceman was likely lactose intolerant, had type O blood, and had 
brown eyes (Keller, et al. 2012). Unfortunately, not all ancient human samples are as complete 
and well-preserved as the Tyrolean Iceman. Genomic information may shed new light on the 
health of ancient individuals, especially when soft tissue and skeletal evidence are unavailable.  
To estimate the health of different individuals, genetic information can be converted into 
a quantitative measure of hereditary disease burden, which we refer to as a genetic risk score 
(GRS). GRS have already been used to estimate disease risk in modern humans (Chatterjee, et al. 
2016). Assuming that disease loci act independently, one way to calculate GRS is to sum the 
number of risk alleles across all disease loci after weighting each allele by its effect size (Corona, 
et al. 2013). The majority of known disease alleles have been identified in present-day Europeans 
through genome wide association studies (GWAS) using microarrays, which are known to 
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contain a biased set of genetic variants (Lachance and Tishkoff 2013). Despite this bias, genetic 
risk scores can still be informative about disease risk. For example, GRS for breast, colorectal, 
and bladder cancer and coronary heart disease accurately predict risk of each disease while 
offering insights into prevention and treatment options (Chatterjee, et al. 2016). Not only can 
GRS be applied to specific traits, but genetic risk can also be estimated for the entire genome.  
One significant limitation of ancient DNA studies is that most genomes are not complete, 
which makes it more challenging to estimate disease risk. Genomes may be incomplete due to 
contamination (Orlando, et al. 2015), DNA degradation (Hofreiter, et al. 2015), or low coverage 
sequencing, as has been the case with large cohort studies (Mathieson, et al. 2015; Lazaridis, et 
al. 2016). One approach to address missing genomic data is to impute genotypes at disease-
associated loci (Sainz, et al. 1989; Li, Willer, et al. 2009). However, imputation of ancient 
genotypes is challenging because of small sample sizes. To avoid imputation errors, genetic risk 
scores for each ancient sample can be calculated using only loci with successful genotype calls 
(i.e. genetic risk scores for each sample use a different set of disease loci). Each ancient genome 
can then be compared to modern genomes at a matched set of disease loci to generate 
standardized GRS percentiles, which enables comparisons between different ancient genomes. 
There has been recent debate about whether rates of sequence change in human genomes 
have increased over time. Hawks, et al. (2007) suggest that rates of adaptive evolution have been 
accelerating over the last 40,000 years, especially within the last 5,000 years. The holocene has 
brought new selective pressures associated with the transition from hunting and gathering to 
agricultural practices (Hawks, et al. 2007). Genes involved in subsistence and dietary changes 
along with disease resistance genes show strong positive selection (Hawks, et al. 2007; Field, et 
al. 2016). Others have argued that there has not been enough time for selection to expel 
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deleterious alleles that lead to evolutionary mismatches between our genomes and modern 
environments (Cordain, et al. 2005). More recently, modern medicine and changes in living 
conditions may have led to the relaxation of selective pressures within the last century. Along 
these lines, Lynch (2016) argues that there has been a substantial increase in the mutational load 
of modern humans (on the order of 1% reduction in fitness per generation). However, Roth and 
Wakeley (2016) contend that the relaxation of selective pressures is not as severe as suggested 
by Lynch (2016).  
With this debate in mind, our study estimated the genomic health of ancient individuals 
by combining disease-association information from the NHGRI-EBI GWAS Catalog with 
publicly available genomes of ancient hominin samples. We investigated relationships between 
genetic disease risk and sample age. We further explored this dataset by determining whether 
genetic risks vary for individuals who practiced different types of subsistence and examined 
whether ancient GRS follow a geographic cline. Finally, we probed differences in genomic 
health between modern and ancient hominins by calculating genetic risk scores for different 
disease categories. 
 
Materials and Methods 
Disease-associated Loci 
The set of all known autosomal disease-associated alleles was downloaded from the NHGRI-EBI 
Catalog of published GWAS studies (www.ebi.ac.uk/gwas; last accessed on September 28, 
2016) (Burdett, et al. 2016; MacArthur, et al. 2017). Any non-disease-associated alleles (e.g., 
hair color, blood pressure, and amount of sleep) were removed from consideration. We also 
filtered out disease-associated alleles from the GWAS Catalog that were missing p-value, odds 
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ratio, and/or allele frequency information. When SNPs were associated with the same disease in 
multiple GWAS, we retained the SNP with the strongest disease association (i.e. lowest p-value). 
To ensure independence between variants associated with a given disease, we included only loci 
that were not in linkage disequilibrium with other disease variants. This involved keeping the 
strongest disease association (i.e. lowest p-value) whenever two SNPs were located within 100kb 
of each other. After filtering, we were left with 3180 autosomal disease-associated alleles from 
578 GWAS. We classified all remaining disease-associated loci into nine categories 
(allergy/autoimmune, cancers, cardiovascular, dental/periodontal, gastrointestinal/liver, 
metabolism/weight, miscellaneous, morphological/muscular, and neurological/psychological). 
These disease categories are not mutually exclusive, so a single locus could be grouped into 
multiple categories (e.g., Crohn’s disease is both an autoimmune and a gastrointestinal disease). 
Note that many disease-associated loci tend are older SNPs that have intermediate frequency 
alleles (Lachance 2010). Because of this, many GWAS alleles can also be found in Neanderthal 
and Denisovan genomes. 
 
Ancient Hominin Genomes 
We downloaded all known publicly available ancient hominin genomes (449 genomes as of July 
1, 2016) and identified genotypes at the 3180 focal disease-associated loci. For genomes that 
were only available as alignments to the human reference genome, we called genotypes from 
these alignments using the ‘mpileup’ function in SAMtools (v. 1.3) (Li, Handsaker, et al. 2009; 
Li 2011). We retained ancient hominin samples that had genotype calls at greater than fifty 
percent of the focal 3180 disease-associated loci, after which 147 ancient genomes from 22 
studies remained. This filter was used to ensure sufficient genotype information for subsequent 
Pre-print version. Visit http://digitalcommons.wayne.edu/humbiol/ after publication to acquire the final 
version. 
analyses. Figure 1 displays the geographic locations of the 147 focal ancient individuals, which 
were jittered to clarify densely sampled locations.  
 
Modern Human Genomes 
We downloaded modern human genomes from phase 3 of the 1000 Genomes Project (The 1000 
Genomes Project Consortium 2015), and we integrated this genomic data with our 3180 focal 
disease-associated loci. At each of the 3180 loci, we obtained the allele frequencies for the five 
continental super-populations of modern humans from the 1000 Genomes Project (AFR, AMR, 
EAS, EUR, and SAS).  
 
Genetic Risk Scores 
For each ancient sample, we estimated GRS across all diseases and for each disease category by 
combining genotypic information and effect sizes. All ancient hominins were missing genotypic 
information at some of the disease-associated loci. To account for this missing information, we 
calculated GRS for each ancient individual (𝑖) from the set of disease-associated loci with 
genotypic calls in that individual (𝐿𝑖):  
𝐺𝑅𝑆𝑖 =  ∑ 𝛽𝑙  × (# of copies of the risk allele at locus 𝑙 in ancient individual 𝑖
𝐿𝑖
𝑙=1
 
where 𝛽𝑙 = 𝑙𝑛 (odds ratio at locus 𝑙). Because each ancient sample contains a different set of 
disease-associated loci with genotype calls, GRS are not directly comparable across individuals.  
To enable comparisons across individuals, we converted raw GRS statistics into 
standardized GRS percentiles (see Figure 2 for a pictorial representation). For each ancient 
genome, this involved simulating 100,000 modern individuals at a matched set of disease loci. 
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Genotypes at disease loci were simulated for 20,000 modern individuals for each of the five 
super-population from the 1000 Genomes Project (AFR, AMR, EAS, EUR, and SAS). Each 
diploid genotype was drawn from a binomial distribution using the ‘rbinom’ function in R where 
the probability of drawing each risk allele is equal to the allele frequency for the given super-
population. These simulations assume that disease loci are independent (i.e. they are in linkage 
equilibrium). Sites that were uncalled in the focal ancient genome were masked in the 
simulations of modern genomes. Genetic risk scores were then calculated for each modern 
individual (𝑗) using a matched set of called loci (𝐿𝑖) for each focal ancient individual (𝑖): 
𝐺𝑅𝑆𝑖,𝑗 =  ∑ 𝛽𝑙  × (# of copies of the risk allele at locus 𝑙 in modern individual 𝑗)
𝐿𝑖
𝑙=1
 
Then, we compared the genetic risk score of each ancient individual to the distribution of the 
simulated modern genetic risk scores using the empirical cumulative density function (ecdf) 
function in R. This enabled us to obtain the percentile rank of each ancient sample relative to 
modern individuals, i.e. the standardized GRS percentile of each ancient genome. We repeated 
this standardization process for each ancient genome, then used the standardized GRS percentiles 
to compare genetic risk amongst ancient individuals and between ancient and modern hominins. 
Higher percentiles indicate less healthy genomes. Standardized GRS percentiles were calculated 
for the set of all combined diseases and for each disease category. Ancient genomes with risk 
scores below the range of their matched set of modern genomes have standardized GRS 
percentiles of 0%, and ancient genomes with risk scores above the range of their matched set of 
modern genomes have standardized GRS percentiles of 100%. An R Shiny (Chang, et al. 2017) 
interactive web application of our results can be found at: http://popgen.gatech.edu/ancient-
health/. 
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Statistical Tests 
For the set of all disease-associated SNPs and each disease category, we tested for differences 
between the GRS of modern humans and ancient hominins. By definition, the GRS percentiles of 
modern humans follow a uniform distribution that ranges between zero and one. If ancient 
hominins have the same genomic risk of disease as modern humans, the standardized GRS 
percentile of ancient samples will also be uniformly distributed. We used a Kolmogorov-
Smirnov test to determine whether the distribution of ancient hominin standardized GRS 
percentiles is, in fact, uniformly distributed. With Wilcoxon signed rank tests and continuity 
corrections, we also tested for a shift in the ancient hominin standardized GRS percentile 
distribution compared to the expectation of the modern human distribution (centered around 0.5).  
Amongst the ancient hominin samples, we investigated whether there are relationships 
between standardized GRS percentile and sample age, mode of subsistence, and geographic 
location. These tests were run for all disease loci (overall GRS percentiles) and by disease 
category. We separated ancient samples into six sample age bins (n = number of samples; < 3500 
[n = 20], 3500-4999 [n = 48], 5000-6499 [n = 34], 6500-7999 [n = 10], 8000-9499 [n = 24], and 
≥ 9500 years before present [n = 11]). We then tested whether there is a difference in 
standardized GRS percentile based on sample age bin using a Kruskal-Wallis test. The Kruskal-
Wallis test is a rank-based nonparametric test that can be used to determine if the differences 
between two or more groups are significant. Following rejection of this test, we performed post-
hoc multiple pairwise comparisons using Dunn tests to determine which ages were significantly 
different from each other. Dunn tests generate z-statistics from rank sums. The Benjamini-
Hochberg method was used to correct for multiple comparisons. We also used a Jonckheere-
Terpstra test, similar to Kruskal-Wallis except that the alternative hypothesis is ordered, to 
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determine whether standardized GRS percentile increased with sample age bin. Mode of 
subsistence varies across ancient samples (n = number of samples; agriculturalist [n = 106], 
hunter-gatherer [n = 22], and pastoralist [n = 19]). Differences in standardized GRS percentiles 
due to mode of subsistence were assessed by Kruskal Wallis tests followed by post-hoc pairwise 
multiple comparisons with Dunn tests. These non-parametric tests do not require groups to have 
equal sample sizes. Using Pearson’s correlation, we also tested for an association between 
standardized GRS percentile and North-South (latitude) or East-West (longitude) gradients. 
 
Results 
Overall Genetic Risks 
On the whole, ancient samples had GRS that were similar to individuals living in the present 
(Figure 3A; Supplemental Table S1). Figure 3A shows that the distribution of standardized GRS 
percentiles of ancient individuals spans the full range of modern humans. In general, most GRS 
scores are evenly distributed. However, there is an excess of ancient hominins who have 
standardized GRS percentiles below 5%, which causes the distribution of standardized GRS 
percentiles to be positively skewed (Kolmogorov-Smirnov test, D = 0.265, p-value = 2.0410-9). 
Using a Wilcoxon signed rank test, we find that the ancient samples have, on average, lower 
predicted genomic risk than modern humans (Table 1). However, GRS calculations for ancient 
samples may underestimate the total amount of genetic risk, as many disease alleles that 
segregated in the past remain undiscovered. 
Data quality of the ancient genomes varies across samples, so we also tested whether 
there were any systematic biases in GRS calculations due to sample quality. Both sequencing 
coverage and the proportion of disease loci that are called may potentially affect whether an 
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individual has a high or low GRS. Based on Pearson’s correlation, there is a weak, yet 
significant, positive relationship between standardized GRS percentiles and sequencing coverage 
for ancient samples (Figure 4A, R2 = 0.087, p-value = 3.010-4). However, this pattern may be 
driven by a small number of outliers, including the Altai Neandertal genome (sequencing 
coverage: 52x, standardized GRS percentile: 97%). Encouragingly, standardized GRS percentiles 
are largely independent of the proportion of disease-associated loci that are able to be 
successfully called in each ancient sample (Figure 4B, R2 = 0.013, p-value = 0.17). Taken 
together, these patterns indicate that our GRS calculations are largely free of biases due to 
sample quality. 
 
Effects of Sample Age. Figure 3A clearly shows that disease risk varies greatly amongst 
ancient hominins, so we investigated whether genetic risk scores follow a temporal pattern. 
Samples were binned into six age ranges, the most recent of which includes individuals that lived 
less than 3500 years before present and the oldest of which includes individuals who lived at 
least 9500 years before present (BP). Among ancient samples, there is a difference in the 
standardized GRS percentile based on sample ages (Kruskal-Wallis test, 2 = 15.24, df = 5, p-
value = 0.009). From Figure 3B, it is evident that the oldest samples are at much greater genetic 
risk than more recent samples. We compared standardized GRS percentiles between pairs of 
sample age ranges using Dunn tests with Benjamini-Hochberg corrections and found that the 
oldest age range (≥ 9500 years BP) is significantly higher than the two most recent age ranges (< 
3500 and 3500-4999 years BP, p-values < 0.007). Following up on this result, we examined 
whether genetic risks progressively improved with time. Results of a Jonckheere-Terpstra test 
appear to support this proposition (p-value = 0.001; Table 1), as genetic disease risk increased 
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with later age ranges. This temporal trend is not due to differences in sequence coverage. Our 
results are robust to the inclusion or exclusion of archaic hominins: when Neanderthal and 
Denisovan samples are removed, the oldest age class has a median GRS percentile of 0.88. 
 
Subsistence Type. The number of risk alleles in each ancient genome may also vary by the 
mode of subsistence, i.e. whether individuals practiced a hunter-gatherer, agricultural, or pastoral 
lifestyle. We tested this hypothesis by performing a Kruskal-Wallis test. Comparisons of ancient 
standardized GRS indicate that form of subsistence affects estimated genetic risk of disease 
(Table 1). Following up on this result, we used a post-hoc Dunn test with Benjamini-Hochberg 
correction to determine which types of subsistence are different from each one another. 
Pastoralists have significantly lower standardized GRS percentiles than agriculturalists and 
hunter-gatherers, while the standardized GRS percentiles are not significantly different between 
agriculturalists and hunter-gatherers (Table 2). Figure 3C shows that the distribution of 
standardized GRS percentiles for ancient pastoralists is shifted into to the healthy range of 
modern humans. We find that the genomes of ancient pastoralists have standardized GRS 
percentiles almost exclusively below the 50th percentile of modern humans. In contrast, 
predictions of disease risk in the genomes of ancient agriculturalists and hunter-gatherers span 
the full range of modern humans.  
One possible concern is that sequencing coverage and the proportion of disease-
associated loci that were successfully called vary by subsistence type (Kruskal-Wallis tests, p-
values = 0.03 and 0.01, Figure 4E and 4F, respectively). Differences in sequencing coverage 
between pastoralists and hunter-gatherers appear to be driven by three older hominin samples – 
Altai Neandertal (52x), Ust’-Ishim (42x), and Denisovan (30x). However, these differences in 
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sequencing coverage do not lead to significant differences in the proportion of disease-associated 
loci that are called in the genomes of pastoralists and hunter-gatherers.  
 
Geographic Patterns.  We tested whether genetic estimates of disease risks vary 
geographically (Table 1). Comparing standardized GRS percentiles and latitude, we find that 
northern ancient individuals tend to have healthier genomes (Pearson correlation test, r = -0.23, 
p-value = 5.0  10-3). Interpretation of these results should be tempered by two considerations: 1) 
most of the ancient samples with sequence data were discovered in Eurasia and 2) there is 
substantial heterogeneity in genetic risk scores across space. In contrast to latitudinal patterns, 
the relationship between standardized GRS percentile and longitude does not reach statistical 
significance (r = -0.13, p-value = 0.11). Despite heterogeneity in standardized GRS percentiles 
and limited sampling, our results suggest that genetic disease risks may have followed a North-
South geographic cline in the past.  
 
Disease Categories 
Which types of diseases drive differences in genetic risk scores between ancient and 
modern individuals? To address this question, we also estimated genetic risk of ancient hominins 
for nine disease categories (Supplemental Table S1). On average, ancient individuals had 
significantly lower genetic risk of cancers, miscellaneous diseases, and 
neurological/psychological diseases than modern humans (Figure 5A; p-values < 0.05). Table 1 
lists summary statistics and p-values from Wilcoxon signed ranked tests for each disease 
category. Only cardiovascular-associated diseases were predicted to have greater risk in ancient 
hominins compared to modern humans (p-value = 1.810-5). Risks of allergy/autoimmune, 
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morphological/muscular, metabolism/weight, and dental/periodontal diseases were not 
significantly different between ancient and modern hominins (p-values > 0.05). Thus, the genetic 
disease burden of ancient hominins appears to be less than modern humans due to reduced risk of 
cancer and neurological disease along with other unclassified diseases. 
 
Effects of Sample Age with Respect to Disease Categories. We calculated genetic risks for nine 
disease categories to determine whether temporal trends were consistent across each disease 
type. Figure 5B displays the standardized GRS percentile by disease category summarized for 
each sample age range. Broadly speaking, we find that genetic disease risks change over time. 
Some disease categories show progressive changes over time. Using Jonckheere-Terpstra tests, 
we find that older samples have higher standardized GRS percentiles for allergy/autoimmune 
diseases, cancers, and gastrointestinal/liver diseases (p-values < 0.05). Temporal trends for 
metabolic diseases were marginally significant (p-value = 0.054). See Table 1 for complete 
results of Jonckheere-Terpstra tests by disease category. Taken together, the time-dependent 
results suggest that more recent ancient hominins have lower disease load due to reduced risk of 
immune-related and gastrointestinal diseases, cancer, and metabolism-related disorders. 
 
Subsistence Type and Disease Categories. We tested whether differences in genetic risk for 
ancient individuals with different modes of subsistence were consistent across all disease 
categories or whether a single disease category drove disparities in genetic risk between 
subsistence groups. Using Kruskal-Wallis tests, we find that form of subsistence affects 
predicted genetic risk of allergy/autoimmune diseases, cancers, dental/periodontal diseases, and 
gastrointestinal/liver diseases in ancient individuals (Figure 5C). Table 1 includes full results 
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from the Kruskal-Wallis test for each disease category. For each significant disease category, we 
also performed post-hoc Dunn tests with Benjamini-Hochberg correction; the z-statistics and p-
values from these tests are displayed in Table 2. Both the allergy/autoimmune and 
gastrointestinal/liver disease categories (which share many of the same disease-associated loci) 
show significantly lower genetic risk in pastoralists than agriculturalists and hunter gatherers. 
Pastoralists also have significantly reduced risk for cancer compared to agriculturalists. 
Agriculturalists have a higher genetic risk for dental/periodontal diseases than hunter-gatherers 
and pastoralists. In general, pastoralists possess extremely healthy genomes, especially for 
cancers and immune-related, periodontal, and gastrointestinal diseases. 
 
Geographic Patterns and Disease Categories. Finally, we examined geographic patterns in 
genetic risk scores for each disease category using Pearson correlation tests (see Table 1 for 
results). For most disease types, estimates of genetic risk did not follow a geographic cline. 
However, decreased risk of disease in northern ancient individuals appears to be driven by two 
disease categories: cancer (r = -0.29) and dental/periodontal diseases (r = -0.20). This negative 
correlation between latitude and standardized GRS percentile is even stronger amongst Eurasian 
ancient samples (cancer: r = -0.33; dental / periodontal diseases: r = -0.22). Focusing on 
longitude, we estimate that the genetic risk of cardiovascular diseases was lower for ancient 
individuals in the east compared to the west (r = -0.20). This trend is slightly weaker when 
comparing only individuals from Eurasia (r = -0.18). 
 
Ancient Precision Medicine 
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Although there are overarching patterns of risk based on type of subsistence and sample age, 
each ancient individual has their own unique disease profile. These ancient disease risk profiles 
are summarized in Table S1 and can be viewed via an interactive web application: 
http://popgen.gatech.edu/ancient-health/. We found that the Altai Neandertal had poor genomic 
health, with a standardized GRS of 97%. This was due in part to high risk for immune-related 
diseases, cancers, gastrointestinal and liver diseases, metabolic-related disorders, and 
morphological and muscular diseases. However, the Altai Neandertal genome did not have an 
elevated number of risk alleles for all disease classes – we estimated a low risk for 
cardiovascular disease and close to average risk for periodontal and miscellaneous diseases. Our 
estimation of genetic risk of cardiovascular disease for the Tyrolean Iceman supports previous 
evidence that this ancient man had a predisposition for this disease (Keller, et al. 2012). 
Additionally, the Tyrolean Iceman had high risk for immune-related diseases, gastrointestinal 
diseases, and metabolic-related disorders. Despite these elevated risks, we also inferred that the 
genome of the Iceman was relatively healthy for morphological and neurological diseases. 
 
Discussion 
Integrating ancient DNA with knowledge of disease associated loci from modern populations 
provides new insights into past human health. Overall, we find that the GRS percentiles of 
ancient hominins span the full range of modern humans. There are some ancient individuals 
whose genomes place them among the healthiest or least healthy individuals living in the 
present. Ancient individuals are enriched for standardized GRS percentiles that are below 5% 
(Figure 3A), which may partially be explained by the fact that our set of known disease-
associated loci only includes genetic variants that segregate in modern populations. Thus, we are 
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excluding disease variants that segregated in the past and possibly underestimating the GRS 
percentile of ancient individuals, i.e. predicted scores are lower than the true genetic disease risk.  
 The genomic health of ancient individuals appears to have improved over time (Figure 
3B). This calls into question the idea that genetic load has been increasing in human populations 
(Lynch 2016). However, there exists a perplexing pattern: ancient individuals who lived within 
the last few thousand years have healthier genomes, on average, than present day humans. This 
deviation from the observed temporal trend of improved genomic health opens up the possibility 
that deleterious mutations have accumulated in human genomes in the recent past. The data 
presented here do not provide adequate information to address this hypothesis, which we leave 
for future follow-up studies.  
Genomic studies have shown that there are lingering effects of ancient introgression on 
the health of modern-day humans. Here, we estimated that the Altai Neandertal genome has an 
elevated risk of neurological diseases (80th percentile compared to modern humans). This is 
consistent with previous findings from electronic health records and patient genomes that linked 
Neandertal haplotypes with increased risk for depression along with tobacco addiction, urinary 
tract disorders, and skin lesions (Simonti, et al. 2016). Other studies have shown that Neandertal 
and Denisovan introgression impacted the immune system of present-day humans (Abi-Rached, 
et al. 2011; Dannemann, et al. 2016; Deschamps, et al. 2016). In our study, the estimated risk of 
immune-related diseases in Neandertal and Denisovan genomes were at the top of the 
distribution (above 100% and 97% of all modern genomes, respectively). A previous study 
showed that archaic alleles at three toll-like receptor genes are associated with reduced microbial 
resistance and increased risk of allergic diseases (Dannemann, et al. 2016). Despite these ill 
effects in modern environments, some archaic alleles are quite prevalent in modern Europeans 
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and Asians likely due to natural selection (Deschamps, et al. 2016). For example, there is 
evidence that significant changes to the coding regions of immunity related genes coincided with 
the shift in subsistence from hunting and gathering to farming (Deschamps, et al. 2016). Our 
results suggest that hunter-gatherers had higher genetic risk of allergy and autoimmune disease 
compared to ancient agriculturalists and pastoralists. 
There have been two great dietary shifts in recent human evolution: 1) the consumption 
of carbohydrate rich diets with the onset of farming (approximately 10,000 years before present) 
and 2) the utilization of processed flour and sugar since the industrial revolution (approximately 
1850 AD). Compared to the other ancient hominins with different forms of subsistence, we 
estimated that ancient pastoralists had healthier genomes due to low risk for immune-related 
diseases, gastrointestinal diseases, and cancers. It is unclear why pastoralists would have the 
lowest risk in these specific disease categories. We caution that this pattern may be the result of 
technical issues, as pastoralists have the smallest sample size (only 19 individuals) and 
geographic range (between 40-90°E longitude and 45-55°N latitude, Figure 1B). Because 
populations that have different subsistence types also differ in other ways, the lower GRS of 
pastoral populations may be due to other factors, including demographic history. 
Comparisons amongst ancient individuals suggest that the transition to agriculture 
brought about changes not only to diet, but also genetic risk for certain diseases. Based on 
genomic data, we inferred that ancient agriculturalists had increased risk for dental caries and 
periodontal diseases. However, slight caution is advised about over interpreting this pattern as 
dental caries and periodontal diseases had the smallest number of risk loci (k = 40). Previous 
comparisons of ancient skeletal remains showed that hunter-gatherers had fewer caries than early 
agriculturalists (Tillier, et al. 1995; Kerr 1998; Trinkaus, et al. 2000; Lebel and Trinkaus 2002). 
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The greater prevalence of dental caries in early agriculturalists may be partially due to 
differences in oral microbiota diversity, as ancient hunter-gatherers were less likely to have 
periodontal disease-associated taxa in calcified dental plaques (Adler, et al. 2013).  
We note that genomic health does not necessarily equate to phenotypic health. Genetic 
risk scores are not deterministic, instead they merely indicate whether an individual has a 
predisposition to a particular disease. In addition, alleles that contribute to disease in modern 
environments may not have had the same effects in past environments. Because of the large 
genetic distances between modern humans and archaic hominins, we caution against over-
interpreting genomic estimates of Neanderthal and Denisovan health. 
 Genomic studies, such as this one, provide an opportunity for incomplete or poorly 
preserved ancient samples to contribute valuable information about the health and disease status 
of our ancestors. As more ancient hominin genomes are sequenced and new disease-associated 
loci are identified, there will be unprecedented opportunities to probe changes in human health 
over time. 
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Table 1. Results of statistical tests between ancient hominin genetic risk scores compared to modern humans (Wilcoxon signed rank 
test) and amongst ancient samples by sample age range (years BP; Jonckheere-Terpstra test), mode of subsistence (Krustal-Wallis 
test), and geographic location (latitude and longitude; Pearson’s correlation tests). Boldface indicates that the p-value is less than 0.05. 
 
Disease Type 
Relative to 
present-day 
Sample age 
range 
Subsistence Latitude Longitude 
(number of loci) V p-value JT 
p-
value 
χ2 
p-
value 
r t 
p-
value 
r t 
p-
value 
All Diseases (3180) 3266 
2.610-
5 
5275 
1.010
-3 
12.3
4 
2.010
-3 
-0.23 -2.86 
5.010
-3 
-0.13 
-
1.6
1 
0.11 
Allergy/Autoimmune 
(770) 
5028 0.51 
4775.
5 
0.035 7.41 0.02 -0.06 -0.69 0.49 -0.09 
-
1.0
9 
0.28 
Cancers (644) 4083 0.03 5049 
2.010
-3 
9.73 0.01 -0.29 -3.71 
3.010
-4 
-0.08 
-
0.9
4 
0.35 
Cardiovascular (232) 7659.5 
1.810-
5 
4523.
5 
0.18 3.26 0.20 -0.06 -0.70 0.49 -0.20 
-
2.4
4 
0.02 
Dental/Periodontal 
(40) 
6203 0.10 
4310.
5 
0.38 
14.1
5 
8.510
-4 
-0.20 -2.48 0.01 -0.13 
-
1.5
7 
0.12 
Gastrointestinal/Liver 
(488) 
4553 0.09 4770 0.033 
17.8
2 
1.410
-4 
-0.15 -1.83 0.07 -0.12 
-
1.4
9 
0.14 
Metabolism/Weight 
(309) 
5052.5 0.54 4674 0.054 2.29 0.32 -0.13 -1.58 0.12 0.03 
0.4
2 
0.68 
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Miscellaneous (532) 3228 
1.910-
5 
4451 0.24 3.63 0.16 -0.06 -0.74 0.46 
-
3.210-
3 
-
0.0
4 
0.97 
Morphological/Muscul
ar (239) 
5898 0.38 
4291.
5 
0.42 3.62 0.16 0.14 1.70 0.09 -0.14 
-
1.6
6 
0.10 
Neurological/Psycholo
gical (459) 
2823 
1.810-
6 
4451.
5 
0.25 2.83 0.24 0.01 0.12 0.90 
2.810-
3 
0.0
3 
0.97 
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Table 2. Statistical results of ancient genetic risk score comparisons between subsistence types 
(AG – Agriculturalist; PA – Pastoralist; HG – Hunter-Gatherer) from Dunn tests with Benjamini-
Hochberg correction, which were performed on disease categories with significant differences 
between subsistence groups (see Table 1). Boldface indicates that the p-value is less than 0.05. 
 
 AG vs HG AG vs PA HG vs PA 
 z p-value z p-value z p-value 
All Diseases -1.35 0.09 2.98 2.110-3 3.38 1.110-3 
Allergy/Autoimmune -1.40 0.08 2.08 0.03 2.70 0.01 
Cancers 0.90 0.18 3.09 3.010-3 1.78 0.06 
Dental/Periodontal 3.04 3.510-3 2.67 5.710-3 -0.15 0.44 
Gastrointestinal/Liver 0.98 0.16 4.21 <1.010-3 2.61 6.810-3 
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Figure 1. Location, age, and subsistence type of ancient hominins. Geographic distribution of 
147 ancient individuals by (A) sample age range in years BP and (B) subsistence type. Over 50% 
of all disease-associated variants were successfully called for each individual, and geographical 
locations were jittered to clarify densely sampled locations. 
 
Figure 2. Schematic of how standardized GRS percentiles were estimated for each ancient 
sample. PokéPlots are shown for each disease locus. Risk alleles are indicated by a red 
hemisphere, protective alleles are indicated by a blue hemisphere, and numbers denote beta 
coefficients. Disease loci without genotypic information in the focal ancient individual are 
masked when estimating GRS for simulated modern humans. Ancient GRS are compared to the 
distribution of the simulated modern GRS to determine the ancient standardized GRS percentile. 
The simulated modern GRS distribution differs for each ancient hominin based on which disease 
loci have known genotypic information.  
 
Figure 3. Ancient genetic risk scores span the full range of modern humans. (A) The distribution 
of ancient standardized GRS percentiles, which includes an excess of healthy individuals below 
the 5th percentile. Ancient standardized GRS percentiles separated by (B) age range and (C) 
subsistence type. Group means indicated by black line and group medians denoted by grey line. 
 
Figure 4. Sequence coverage and sample quality have minimal effect on genetic risk scores. 
Genome coverage (top) and proportion of disease-associated loci called (bottom) by genetic risk 
percentile (left), age range (center), and subsistence type (right). Group means and medians 
indicated by black and grey lines, respectively.  
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Figure 5. Risk radars of genomic health for ancient samples. The length of each spoke 
corresponds to a standardized GRS percentile. Healthy individuals have smaller shapes in risk 
radar plots. (A) Standardized GRS percentile by disease category for all ancient hominins 
summarized as median risk score. The median of genetic disease risk in modern humans is the 
50th percentile. Temporal (B) and subsistence (C) trends of median ancient genetic risk by 
disease category. Disease categories with significant differences (p-value < 0.05) from Table 1 
are denoted by *. 
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